首页 | 本学科首页   官方微博 | 高级检索  
检索        

原发性头痛患者血浆组织型纤溶酶原激活物及其抑制物活性变化的研究
引用本文:龙洁,于学英,白云.原发性头痛患者血浆组织型纤溶酶原激活物及其抑制物活性变化的研究[J].北京医学,1999,0(1):14-17.
作者姓名:龙洁  于学英  白云
作者单位:北京天坛医院神经内科!邮政编码100050
摘    要:本研究应用发色底物法(CS)测定了两类原发性头痛:偏头痛及紧张性头痛患者血浆组织型纤溶酶原激活物(t-PA)及其快速抑制物(PAI-1)活性的变化规律。结果发现:两类原发性头痛患者血浆t-PA活性变化不明显,而PAI-1 活性均明显增高,说明两类原发性头痛患者均存在血管内皮功能损伤及血浆纤溶活性的异常。原发性头痛者中存在着缺血性CVD的高危个体,临床医师应对其引起重视,及时给予针对性治疗,以防止脑梗塞的发生。

关 键 词:原发性  头痛  t-PA  PAI-1  血浆

原发性头痛患者血浆组织型纤溶酶原激活物及其抑制物活性变化的研究
Long Jie,Yu Xueying,Bai Yun,et al.原发性头痛患者血浆组织型纤溶酶原激活物及其抑制物活性变化的研究[J].Beijing Medical Journal,1999,0(1):14-17.
Authors:Long Jie  Yu Xueying  Bai Yun  
Institution:Long Jie, Yu Xueying, Bai Yun, et al (Beijing Tiantan Hospital, Beijing 100050)
Abstract:Abstract We detected the changes of activities of tissue type plasminogen activator (t PA) and its rapid inhibitor(PAI 1) in plasma in the patients with migraine and tension type headache(TTH) by chromophore substrate assay. We found that the activities of t PA had no significant changes in plasma in two kinds of idiopathic headache, but the activities of PAI 1 increase significant which implied that there existed the injuries of vascular endothelial cells (VECs) and the abnormalities of fibrinolytic activity in plasma. We think that there present high risk individuals of ischemic cerebral vascular disease among the patients with idiopathic headache. Clinical physician should pay more attention to the patients with migraine or TTH in order to find the prethrombotic individuals and to give the effective treatment, to avoid the occurence of cerebral infarction.
Keywords:Idiopathic headache  Tissue  type plasminogen activator  Plasminogen activator inhibitor  1
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号